BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7397781)

  • 1. Macrophage heterogeneity in tumor resistance: cytostatic and cytotoxic activity of Corynebacterium parvum-activated and proteose peptone-elicited rat macrophages against Moloney sarcoma tumor cells.
    Campbell MW; Sholley MM; Miller GA
    Cell Immunol; 1980 Mar; 50(1):153-68. PubMed ID: 7397781
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of cell-mediated tumour immunity by Corynebacterium parvum.
    Kirchner H; Glaser M; Herberman R
    Nature; 1975 Oct; 257(5525):396-8. PubMed ID: 170531
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible mechanisms underlying the induction of cytotoxic macrophages by Corynebacterium parvum: in vitro induction of cytotoxicity in normal macrophages by immune lymphocytes.
    Cullen RT; Ghaffar A
    J Reticuloendothel Soc; 1978 Oct; 24(4):339-49. PubMed ID: 81874
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of Corynebacterium parvum in the activation of peritoneal macrophages. 1. Association between intracellular C. parvum and cytotoxic macrophages.
    Chapes SK; Haskill S
    Cell Immunol; 1982 Jun; 70(1):65-75. PubMed ID: 7116464
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of Corynebacterium parvum in the activation of peritoneal macrophages. II. Identification of distinguishable anti-tumor activities by macrophage subpopulations.
    Chapes SK; Haskill S
    Cell Immunol; 1983 Feb; 76(1):49-57. PubMed ID: 6219754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation of functionally distinct subpopulations of Corynebacterium parvum-activated macrophages with predominantly stimulatory or suppressive effect on the cell-mediated cytotoxic T cell response.
    Lee KC; Kay J; Wong M
    Cell Immunol; 1979 Jan; 42(1):28-41. PubMed ID: 312146
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the in-vitro antitumor activity of peritoneal cells from mice injected with Corynebacterium parvum and Corynebacterium liquefaciens.
    Toge T; Hattori T
    Hiroshima J Med Sci; 1979 Jun; 28(2):95-101. PubMed ID: 478988
    [No Abstract]   [Full Text] [Related]  

  • 8. Macrophage mediated tumor cell cytotoxicity.
    Kaplan AM; Morahan PS
    Ann N Y Acad Sci; 1976; 276():134-45. PubMed ID: 1071961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumour effects of Corynebacterium parvum in mice.
    Castro JE
    Eur J Cancer (1965); 1974 Feb; 10(2):121-7. PubMed ID: 4435007
    [No Abstract]   [Full Text] [Related]  

  • 10. Further analysis of the anti-tumour effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum.
    Ghaffar A; Cullen RT; Woodruff MA
    Br J Cancer; 1975 Jan; 31(1):15-24. PubMed ID: 1156505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced thermal response of a rat sarcoma by Corynebacterium parvum.
    Shah SA
    Cancer Lett; 1985 Mar; 26(2):235-40. PubMed ID: 3978610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional heterogeneity in macrophages activated by Corynebacterium parvum: characterization of subpopulations with different activities in promoting immune responses and suppressing tumor cell growth.
    Lee KC; Berry D
    J Immunol; 1977 May; 118(5):1530-40. PubMed ID: 323353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation of susceptibility of different Propionibacterium strains to macrophage killing and antitumor activity.
    Roszkowski W; Ko HL; Roszkowski K; Szmigielski S; Jeljaszewicz J; Pulverer G
    Med Microbiol Immunol; 1980; 169(1):1-8. PubMed ID: 7464684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of tumour inhibition by activated macrophages in vitro.
    Orinda DA
    East Afr Med J; 1978 Apr; 55(4):177-81. PubMed ID: 679868
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy.
    Moore K; McBride WH
    Br J Cancer; 1983 Jun; 47(6):797-802. PubMed ID: 6860547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Casual influence of the stimulation of macrophage production by proteose-peptone, in the experimental infection of mice by Plasmodium berghei].
    Arantes SC; Braz LM; Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1994; 49(6):243-5. PubMed ID: 7610336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of pulmonary macrophages in resistance to experimental metastasis.
    Jackson RA; Lill PH; Gangemi JD
    J Leukoc Biol; 1986 Nov; 40(5):575-87. PubMed ID: 3464675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two anti-tumour cytotoxic cells in the peritoneal cavity of rats: natural occurrence, augmentation and partial characterization.
    Inoue Y; Nelson DS
    Aust J Exp Biol Med Sci; 1982 Feb; 60(Pt 1):41-53. PubMed ID: 7092732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor T cells and suppressor macrophages induced by Corynebacterium parvum.
    Lichtenstein A; Murahata R; Sugasawara R; Zighelboim J
    Cell Immunol; 1981 Mar; 58(2):257-68. PubMed ID: 6452218
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of C. parvum therapy on intratumoral macrophage subpopulations.
    McBride WH; Moore K
    Adv Exp Med Biol; 1982; 155():731-6. PubMed ID: 7158508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.